Clicky

Extrawell Pharmaceutical Holdings Ltd(0858)

Description: Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. The company also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, it is involved in the marketing and distribution of imported pharmaceutical products, including Millibar for the treatment of high blood pressure; and development of oral insulin. Further, the company engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holding of gene invention rights. Extrawell Pharmaceutical Holdings Limited is headquartered in Quarry Bay, Hong Kong.


Keywords: Pharmaceutical Products Disease Medication Cell Biology Transfusion Medicine Coagulation Coagulation System Platelet High Blood Pressure Body Fluids Treatment Of High Blood Pressure Virus Infection

Home Page: www.extrawell.com.hk

Devon House
Quarry Bay,
Hong Kong
Phone: 852 2856 1918


Officers

Name Title
Dr. Yi Xie Exec. Chairman & CEO
Dr. Yi Lou Ph.D. Exec. Director
Mr. Yong Cheng Deputy CEO & Exec. Director
Ms. Sau Kuen Wong Company Sec. & Exec. Director
Dr. Yumin Mao Ph.D. Honorary Chairman and Chief Scientific Advisor
Ms. Hong Wu Group Sr. Fin. Mang.
Mr. Youlu Gong GM of Changchun Extrawell Pharmaceutical Co Ltd & Jilin Extrawell Changbaishan Pharmaceutical Co Ltd
Mr. Wenda Huang Financial Controller of CEP & JECP

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 0
Trailing PE: 2.6333
Price-to-Book MRQ: 0.1599
Price-to-Sales TTM: 2.9987
IPO Date: 1999-03-10
Fiscal Year End: March
Full Time Employees: 172
Back to stocks